![]() |
|
|
Vol. 298, Issue 2, 403-410, August 2001
1-Adrenergic Receptors: New Insights and
Directions
Department of Pharmacology, the Vascular Biology Research Group,
University of Kentucky, College of Medicine, Lexington, Kentucky
(M.T.P.); and Department of Molecular Cardiology, Lerner Research
Institute, The Cleveland Clinic Foundation, Cleveland, Ohio (D.M.P.)
The adrenergic receptors play a key role in the modulation of
sympathetic nervous system activity as well as a site of action for
many therapeutic agents. The
1-adrenergic receptor
subtypes (
1A-,
1B-,
1D)
are the prime mediators of smooth muscle contraction and hypertrophic
growth, but their characterization in both binding and function have
lagged the other adrenergic family members. Although they are derived
from a related ancestral gene and all nine adrenergic receptor family
members bind the endogenous ligands, epinephrine and norepinephrine,
with roughly similar affinities, there are major differences in the
mode of binding, second messenger utilization, and physiological
effects of the
1-subtypes compared with
- or
2-subtypes. Here, we review the recent literature on
aspects of its binding pocket and how it differs from the
-adrenergic receptor paradigms. We also review the signaling
components and aspects of its function and provide new insights into
its roles in smooth muscle, growth, neurological, and cardiovascular function.
This article has been cited by other articles:
![]() |
J. S. Lyssand, M. C. DeFino, X.-b. Tang, A. L. Hertz, D. B. Feller, J. L. Wacker, M. E. Adams, and C. Hague Blood Pressure Is Regulated by an {alpha}1D-Adrenergic Receptor/Dystrophin Signalosome J. Biol. Chem., July 4, 2008; 283(27): 18792 - 18800. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O-Uchi, H. Sasaki, S. Morimoto, Y. Kusakari, H. Shinji, T. Obata, K. Hongo, K. Komukai, and S. Kurihara Interaction of {alpha}1-Adrenoceptor Subtypes With Different G Proteins Induces Opposite Effects on Cardiac L-type Ca2+ Channel Circ. Res., June 6, 2008; 102(11): 1378 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Lee, A. Kyrozis, V. Chevaleyre, L.-M. Kow, N. Devidze, Q. Zhang, A. M. Etgen, and D. W. Pfaff Estradiol modulation of phenylephrine-induced excitatory responses in ventromedial hypothalamic neurons of female rats PNAS, May 20, 2008; 105(20): 7333 - 7338. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Lynch and J. G. Ryall Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease Physiol Rev, April 1, 2008; 88(2): 729 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T.C.C. Patrao, D. B.C. Queiroz, G. Grossman, P. Petrusz, M. d. F. M. Lazari, and M. C. W. Avellar Cloning, expression and immunolocalization of {alpha}1-adrenoceptor in different tissues from rhesus monkey and human male reproductive tract Mol. Hum. Reprod., February 1, 2008; 14(2): 85 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, S. F. Perry, S. Aris-Brosou, C. Selva, and T. W. Moon Characterization and functional divergence of the {alpha}1-adrenoceptor gene family: insights from rainbow trout (Oncorhynchus mykiss) Physiol Genomics, December 19, 2007; 32(1): 142 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Shanler and A. L. Ondo Successful Treatment of the Erythema and Flushing of Rosacea Using a Topically Applied Selective {alpha}1-Adrenergic Receptor Agonist, Oxymetazoline Arch Dermatol, November 1, 2007; 143(11): 1369 - 1371. [Full Text] [PDF] |
||||
![]() |
A. Gericke, P. Martinka, I. Nazarenko, P. B. Persson, and A. Patzak Impact of {alpha}1-adrenoceptor expression on contractile properties of vascular smooth muscle cells Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1215 - R1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dunaway, Qianli Yu, and D. F. Larson Effect of acute alpha adrenergic stimulation on cardiac function Perfusion, July 1, 2007; 22(4): 289 - 292. [Abstract] [PDF] |
||||
![]() |
N. Gong, I. Bodi, C. Zobel, A. Schwartz, J. D. Molkentin, and P. H. Backx Calcineurin Increases Cardiac Transient Outward K+ Currents via Transcriptional Up-regulation of Kv4.2 Channel Subunits J. Biol. Chem., December 15, 2006; 281(50): 38498 - 38506. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Molina-Munoz, M. T. Romero-Avila, and J. A. Garcia-Sainz Insulin-Like Growth Factor-I Induces {alpha}1B-Adrenergic Receptor Phosphorylation through Gss{gamma} and Epidermal Growth Factor Receptor Transactivation Mol. Endocrinol., November 1, 2006; 20(11): 2773 - 2783. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, R. R. Hodges, C. Funaki, D. Zoukhri, R. J. Gaivin, D. M. Perez, and D. A. Dartt Effects of {alpha}1D-adrenergic receptors on shedding of biologically active EGF in freshly isolated lacrimal gland epithelial cells Am J Physiol Cell Physiol, November 1, 2006; 291(5): C946 - C956. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shi, Z.-H. Duan, R. Papay, E. Pluskota, R. J. Gaivin, C. A. de la Motte, E. F. Plow, and D. M. Perez Novel {alpha}1-Adrenergic Receptor Signaling Pathways: Secreted Factors and Interactions with the Extracellular Matrix Mol. Pharmacol., July 1, 2006; 70(1): 129 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Szot, S. S. White, J. L. Greenup, J. B. Leverenz, E. R. Peskind, and M. A. Raskind Compensatory Changes in the Noradrenergic Nervous System in the Locus Ceruleus and Hippocampus of Postmortem Subjects with Alzheimer's Disease and Dementia with Lewy Bodies J. Neurosci., January 11, 2006; 26(2): 467 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Fernando and A. P. Heaney {alpha}1-Adrenergic Receptor Antagonists: Novel Therapy for Pituitary Adenomas Mol. Endocrinol., December 1, 2005; 19(12): 3085 - 3096. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Marti, R. Miquel, K. Ziani, R. Gisbert, M. D. Ivorra, E. Anselmi, L. Moreno, V. Villagrasa, D. Barettino, and P. D'Ocon Correlation between mRNA levels and functional role of {alpha}1-adrenoceptor subtypes in arteries: evidence of {alpha}1L as a functional isoform of the {alpha}1A-adrenoceptor Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1923 - H1932. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Gibbons, S. A. Vernino, H. Kaufmann, and R. Freeman l-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy Neurology, October 11, 2005; 65(7): 1104 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Mulder, C. J. Tack, A. J. Olthaar, P. Smits, F. C. G. J. Sweep, and R. R. Bosch Adrenergic receptor stimulation attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes by inhibiting GLUT4 translocation Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E627 - E633. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Miquel, R. Gisbert, E. Serna, F. Perez-Vizcaino, E. Anselmi, M. A. Noguera, M. D. Ivorra, and M. P. D'Ocon Acute and Chronic Captopril, but Not Prazosin or Nifedipine, Normalize Alterations in Adrenergic Intracellular Ca2+ Handling Observed in the Mesenteric Arterial Tree of Spontaneously Hypertensive Rats J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 359 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hosoda, T.-a. Koshimizu, A. Tanoue, Y. Nasa, R. Oikawa, T. Tomabechi, S. Fukuda, H. Shinoura, S. Oshikawa, S. Takeo, et al. Two {alpha}1-Adrenergic Receptor Subtypes Regulating the Vasopressor Response Have Differential Roles in Blood Pressure Regulation Mol. Pharmacol., March 1, 2005; 67(3): 912 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Gonzalez-Cabrera, T. Shi, J. Yun, D. F. McCune, B. R. Rorabaugh, and D. M. Perez Differential Regulation of the Cell Cycle by {alpha}1-Adrenergic Receptor Subtypes Endocrinology, November 1, 2004; 145(11): 5157 - 5167. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Bockman, M. R. Bruchas, W. Zeng, K. A. O'Connell, P. W. Abel, M. A. Scofield, and F. J. Dowd Submandibular Gland Acinar Cells Express Multiple {alpha}1-Adrenoceptor Subtypes J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 364 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-a. Koshimizu, G. Tsujimoto, A. Hirasawa, Y. Kitagawa, and A. Tanoue Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human {alpha}1D- and {alpha}1B-adrenergic receptors Cardiovasc Res, September 1, 2004; 63(4): 662 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Kang, K. S. Yi, N. S. Kwon, K.-H. Park, U.-H. Kim, K. J. Baek, and M.-J. Im {alpha}1B-Adrenoceptor Signaling and Cell Motility: GTPase FUNCTION OF Gh/TRANSGLUTAMINASE 2 INHIBITS CELL MIGRATION THROUGH INTERACTION WITH CYTOPLASMIC TAIL OF INTEGRIN {alpha} SUBUNITS J. Biol. Chem., August 27, 2004; 279(35): 36593 - 36600. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Chen, G. Rogge, C. Hague, D. Alewood, B. Colless, R. J. Lewis, and K. P. Minneman Subtype-selective Noncompetitive or Competitive Inhibition of Human {alpha}1-Adrenergic Receptors by {rho}-TIA J. Biol. Chem., August 20, 2004; 279(34): 35326 - 35333. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Barki-Harrington, C. Perrino, and H. A Rockman Network integration of the adrenergic system in cardiac hypertrophy Cardiovasc Res, August 15, 2004; 63(3): 391 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ramsay, I. C. Carr, J. Pediani, J. F. Lopez-Gimenez, R. Thurlow, M. Fidock, and G. Milligan High-Affinity Interactions between Human {alpha}1A-Adrenoceptor C-Terminal Splice Variants Produce Homo- and Heterodimers but Do Not Generate the {alpha}1L-Adrenoceptor Mol. Pharmacol., August 1, 2004; 66(2): 228 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hague, M. A. Uberti, Z. Chen, R. A. Hall, and K. P. Minneman Cell Surface Expression of {alpha}1D-Adrenergic Receptors Is Controlled by Heterodimerization with {alpha}1B-Adrenergic Receptors J. Biol. Chem., April 9, 2004; 279(15): 15541 - 15549. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hague, Z. Chen, A. S. Pupo, N. A. Schulte, M. L. Toews, and K. P. Minneman The N Terminus of the Human {alpha}1D-Adrenergic Receptor Prevents Cell Surface Expression J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 388 - 397. [Abstract] [Full Text] |
||||
![]() |
S. L. Kirstein and P. A. Insel Autonomic Nervous System Pharmacogenomics: A Progress Report Pharmacol. Rev., March 1, 2004; 56(1): 31 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Perez-Rivera, G. D. Fink, and J. J. Galligan Increased Reactivity of Murine Mesenteric Veins to Adrenergic Agonists: Functional Evidence Supporting Increased {alpha}1-Adrenoceptor Reserve in Veins Compared with Arteries J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 350 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A Ross, B. R Rorabaugh, D. Chalothorn, J. Yun, P. J Gonzalez-Cabrera, D. F McCune, M. T Piascik, and D. M Perez The {alpha}1B-adrenergic receptor decreases the inotropic response in the mouse Langendorff heart model Cardiovasc Res, December 1, 2003; 60(3): 598 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xiang and B. K. Kobilka Myocyte Adrenoceptor Signaling Pathways Science, June 6, 2003; 300(5625): 1530 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gisbert, F. Perez-Vizcaino, A. L. Cogolludo, M. A. Noguera, M. D. Ivorra, J. Tamargo, and P. D'Ocon Cytosolic Ca2+ and Phosphoinositide Hydrolysis Linked to Constitutively Active {alpha}1D-Adrenoceptors in Vascular Smooth Muscle J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1006 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chalothorn, D. F. McCune, S. E. Edelmann, K. Tobita, B. B. Keller, R. D. Lasley, D. M. Perez, A. Tanoue, G. Tsujimoto, G. R. Post, et al. Differential Cardiovascular Regulatory Activities of the {alpha}1B- and {alpha}1D-Adrenoceptor Subtypes J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1045 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Gonzalez-Cabrera, R. J. Gaivin, J. Yun, S. A. Ross, R. S. Papay, D. F. McCune, B. R. Rorabaugh, and D. M. Perez Genetic Profiling of alpha 1-Adrenergic Receptor Subtypes by Oligonucleotide Microarrays: Coupling to Interleukin-6 Secretion but Differences in STAT3 Phosphorylation and gp-130 Mol. Pharmacol., May 1, 2003; 63(5): 1104 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Vittorio, C. C. Lang, S. D. Katz, M. Packer, D. M. Mancini, and U. P. Jorde Vasopressor Response to Angiotensin II Infusion in Patients With Chronic Heart Failure Receiving {beta}-Blockers Circulation, January 21, 2003; 107(2): 290 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Teeters, C. Erami, H. Zhang, and J. E. Faber Systemic alpha 1A-adrenoceptor antagonist inhibits neointimal growth after balloon injury of rat carotid artery Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H385 - H392. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Reja, A. K. Goodchild, and P. M. Pilowsky Catecholamine-Related Gene Expression Correlates With Blood Pressures in SHR Hypertension, September 1, 2002; 40(3): 342 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Rokosh and P. C. Simpson Knockout of the alpha 1A/C-adrenergic receptor subtype: The alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure PNAS, July 9, 2002; 99(14): 9474 - 9479. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tanoue, M. Koba, S. Miyawaki, T.-a. Koshimizu, C. Hosoda, S. Oshikawa, and G. Tsujimoto Role of the {alpha}1D-Adrenegric Receptor in the Development of Salt-Induced Hypertension Hypertension, July 1, 2002; 40(1): 101 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. A. Janssen and J. F. M. Smits Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1545 - R1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, C. S. Facemire, A. J. Banes, and J. E. Faber Different alpha -adrenoceptors mediate migration of vascular smooth muscle cells and adventitial fibroblasts in vitro Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2364 - H2370. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chalothorn, D. F. McCune, S. E. Edelmann, M. L. Garcia-Cazarin, G. Tsujimoto, and M. T. Piascik Differences in the Cellular Localization and Agonist-Mediated Internalization Properties of the alpha 1-Adrenoceptor Subtypes Mol. Pharmacol., May 1, 2002; 61(5): 1008 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Waldrop, D. Mastalerz, M. T. Piascik, and G. R. Post alpha 1B- and alpha 1D-Adrenergic Receptors Exhibit Different Requirements for Agonist and Mitogen-Activated Protein Kinase Activation to Regulate Growth Responses in Rat 1 Fibroblasts J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 83 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, C. S. Facemire, A. J. Banes, and J. E. Faber Different alpha -adrenoceptors mediate migration of vascular smooth muscle cells and adventitial fibroblasts in vitro Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2364 - H2370. [Abstract] [Full Text] [PDF] |
||||